StockWatch
·
Pharmaceuticals
Board Meeting29 May 2026, 03:49 pm

Haleos Labs Approves FY26 Results, ₹1.501 Dividend

AI Summary

Haleos Labs Ltd's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. They recommended a dividend of ₹1.501 (15%) per equity share for FY26, subject to shareholder approval. The board also noted the resignation of Independent Director Mrs. Sundaramma Patibandla, reconstituted sub-committees, and approved the reappointment of Mrs. Sudeepthi Gopineedi as Whole-time Director for 5 years, subject to shareholder approval. They approved overall managerial remuneration payable to Executive Director(s) and will conduct a postal ballot for shareholder approvals on key matters.

Key Highlights

  • Approved audited FY26 standalone and consolidated financial results.
  • Recommended a dividend of ₹1.501 (15%) per equity share for FY26.
  • Mrs. Sundaramma Patibandla resigned as Independent Director.
  • Reappointed Mrs. Sudeepthi Gopineedi as Whole-time Director for 5 years, subject to shareholder approval.
  • To conduct postal ballot for shareholder approvals on key matters.